{"id":"W4379967447","doi":"10.1038/s41591-023-02398-1","title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; University of California, San Diego; University of North Carolina at Chapel Hill; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; AveXis; Zynerba Pharmaceuticals; National Institute of Child Health and Human Development; Children's Hospital Colorado; GW Pharmaceuticals; Ionis Pharmaceuticals; International Foundation for CDKL5 Research; Texas Children's Hospital; Ultragenyx Pharmaceutical; Zogenix; MIND Institute, University of California, Davis; ACADIA Pharmaceuticals; University of South Florida; University of Cincinnati; Rush University; LouLou Foundation; Clinical Trial Center, China Medical University Hospital; Mallinckrodt Pharmaceuticals; University of California, Davis; Cincinnati Children's Hospital Medical Center; Emory University; Cleveland Clinic; University of Pennsylvania; Vanderbilt University; Vanderbilt University Medical Center; Marinus Pharmaceuticals; Children's Hospital of Philadelphia; Biogen; International Rett Syndrome Foundation; Simons Foundation","keywords":"Rett syndrome; Placebo; Medicine; Internal medicine; Clinical endpoint; Pediatrics; Clinical trial; Pathology; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001826096,0.001500022,0.002960149,0.0004345261,0.0005357637,0.001287564,0.0009832344,0.002437615,0.01002866],"category_scores_gemma":[0.001586088,0.000633644,0.002847815,0.000407455,0.0008221255,0.001302257,0.0003461876,0.003263805,0.001273422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006978465,"about_ca_system_score_gemma":0.001417693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000937261,"about_ca_topic_score_gemma":0.002887747,"domain_scores_codex":[0.9994434,0.0002538114,0.00003727317,0.0001002984,0.00006530013,0.0000999793],"domain_scores_gemma":[0.9992921,0.0001729079,0.0001755534,0.00006228221,0.00007439575,0.0002226656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9291669,0.01513082,0.0009865727,0.002320831,0.003065116,0.0003046713,0.0001240596,0.0006125426,0.007087903,0.0003752238,0.0050054,0.03582005],"study_design_scores_gemma":[0.9342679,0.06059732,0.00176052,0.0001128665,0.0004865915,0.0001371946,0.00003044039,0.0004295566,0.0002735005,0.0002634936,0.001614763,0.00002577591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9465151,0.01874965,0.001987076,0.002496552,0.001837093,0.01631927,0.004454694,0.0006549053,0.00698563],"genre_scores_gemma":[0.9435148,0.01172442,0.004059612,0.006004397,0.001054594,0.02316411,0.003501865,0.000116039,0.006860164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01002866,"threshold_uncertainty_score":0.03354919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01233716112357668,"score_gpt":0.3183866605019933,"score_spread":0.3060494993784166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}